Monocyte immune signaling pathways

Monocyte immune signaling pathways represent the integrated network of biochemical signals that govern the recruitment, activation, and functional polarization of monocytes during the immune response. These pathways, including the Toll-like receptor (TLR), JAK/STAT, and MAPK cascades, are essential for detecting pathogen-associated molecular patterns (PAMPs) and initiating the production of pro-inflammatory mediators like TNF-alpha and IL-6 [1][2]. In chronic inflammatory conditions such as rheumatoid arthritis and atherosclerosis, dysregulation of these pathways leads to persistent tissue damage and disease progression [3][4]. While these pathways are not a single drug target, many therapeutic agents specifically inhibit individual components—such as JAK inhibitors or monoclonal antibodies against cytokines—to dampen the overactive monocyte response [5]. However, because these pathways are fundamental to host defense, therapeutic modulation carries risks of opportunistic infections and impaired immune surveillance [6].

Other names

Monocyte activation pathwaysMonocyte-macrophage signaling cascadesMyeloid immune signaling

Modulation of monocyte activity through the inhibition of specific receptors (e.g., TNF receptors, IL-1 receptors) or intracellular signaling molecules (e.g., JAK kinases, NF-kappaB) within the broader immune signaling network.